[The experimental study of oxygenated crystalloid cardioplegia assessed by intramyocardial PCO2 monitoring].
D000818:Animals; D002245:Carbon Dioxide / Q000378:metabolism*; D006321:Heart / Q000187:drug effects / Q000503:physiopathology; D006324:Heart Arrest, Induced / Q000379:methods; D066298:In Vitro Techniques; D008991:Monitoring, Physiologic; D009206:Myocardium / Q000378:metabolism*; D010100:Oxygen / Q000627:therapeutic use*; D010313:Partial Pressure; D011188:Potassium / Q000627:therapeutic use; D017680:Potassium Compounds; D011817:Rabbits
D017680:Potassium Compounds; C018369:potassium cardioplegic solution; D002245:Carbon Dioxide; D011188:Potassium; D010100:Oxygen